United States · FDA National Drug Code directory
Levothyroxine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2090_a8f96719-021a-486f-9a9d-2d933573032b
- Product NDC
- 71335-2090
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201203
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 200 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (71335-2090-1) · 71335-2090-1
- 30 TABLET in 1 BOTTLE (71335-2090-2) · 71335-2090-2
- 90 TABLET in 1 BOTTLE (71335-2090-3) · 71335-2090-3
- 60 TABLET in 1 BOTTLE (71335-2090-4) · 71335-2090-4
- 18 TABLET in 1 BOTTLE (71335-2090-5) · 71335-2090-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →